Search research articles
Contact Us
Filters
Showing results (41-50 of 82) with videos related to
Page
of 9
Sort By:
The Journal of Infection
|
July 26, 2005
SEN virus infection among patients on maintenance hemodialysis in southern Taiwan
Chia-Yen Dai, Wan-Long Chuang, Wen-Yu Chang, et al.
BMC Infectious Diseases
|
April 13, 2005
High versus standard doses interferon-alpha in the treatment of naïve chronic hepatitis C patients in Taiwan: a 10-year cohort study
Ming-Lung Yu, Chia-Yen Dai, Shinn-Cherng Chen, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
April 7, 2019
Risk stratification of non-alcoholic fatty liver disease across body mass index in a community basis
Jee-Fu Huang, Pei-Chien Tsai, Ming-Lun Yeh, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 16, 2006
A 24-week course of high-dose interferon-alpha plus ribavirin for Taiwanese chronic hepatitis C patients with persistently normal or near-normal alanine aminotransferase levels
Ming-Lung Yu, Chia-Yen Dai, Li-Po Lee, et al.
The Journal of Infectious Diseases
|
December 3, 2005
Tumor necrosis factor- alpha promoter polymorphism at position -308 predicts response to combination therapy in hepatitis C virus infection
Chia-Yen Dai, Wan-Long Chuang, Wen-Yu Chang, et al.
Hepatology (Baltimore, Md.)
|
October 24, 2006
A simple noninvasive index for predicting long-term outcome of chronic hepatitis C after interferon-based therapy
Ming-Lung Yu, Shi-Ming Lin, Chuan-Mo Lee, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
October 18, 2003
Clinical significance of TT virus (TTV) infection in chronic hepatitis C patients with high dose interferon-alpha therapy in Taiwan: re-evaluated by using new set of TTV primers
Chia Yen Dai, Ming Lung Yu, Zu Yau Lin, et al.
The Kaohsiung Journal of Medical Sciences
|
February 9, 2012
Antinuclear antibody titer and treatment response to peginterferon plus ribavirin for chronic hepatitis C patients
Ming-Yen Hsieh, Chia-Yen Dai, Li-Po Lee, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine
|
August 30, 2006
Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy
Ming-Lung Yu, Wan-Long Chuang, Chia-Yen Dai, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine
|
August 30, 2006
Polymorphism of interferon-gamma gene at position +874 and clinical characteristics of chronic hepatitis C
Chia-Yen Dai, Wan-Long Chuang, Ming-Yen Hsieh, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 82) with videos related to
Sort By:
Page
of 9
The Journal of Infection
|
July 26, 2005
SEN virus infection among patients on maintenance hemodialysis in southern Taiwan
Chia-Yen Dai, Wan-Long Chuang, Wen-Yu Chang, et al.
BMC Infectious Diseases
|
April 13, 2005
High versus standard doses interferon-alpha in the treatment of naïve chronic hepatitis C patients in Taiwan: a 10-year cohort study
Ming-Lung Yu, Chia-Yen Dai, Shinn-Cherng Chen, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
April 7, 2019
Risk stratification of non-alcoholic fatty liver disease across body mass index in a community basis
Jee-Fu Huang, Pei-Chien Tsai, Ming-Lun Yeh, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 16, 2006
A 24-week course of high-dose interferon-alpha plus ribavirin for Taiwanese chronic hepatitis C patients with persistently normal or near-normal alanine aminotransferase levels
Ming-Lung Yu, Chia-Yen Dai, Li-Po Lee, et al.
The Journal of Infectious Diseases
|
December 3, 2005
Tumor necrosis factor- alpha promoter polymorphism at position -308 predicts response to combination therapy in hepatitis C virus infection
Chia-Yen Dai, Wan-Long Chuang, Wen-Yu Chang, et al.
Hepatology (Baltimore, Md.)
|
October 24, 2006
A simple noninvasive index for predicting long-term outcome of chronic hepatitis C after interferon-based therapy
Ming-Lung Yu, Shi-Ming Lin, Chuan-Mo Lee, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
October 18, 2003
Clinical significance of TT virus (TTV) infection in chronic hepatitis C patients with high dose interferon-alpha therapy in Taiwan: re-evaluated by using new set of TTV primers
Chia Yen Dai, Ming Lung Yu, Zu Yau Lin, et al.
The Kaohsiung Journal of Medical Sciences
|
February 9, 2012
Antinuclear antibody titer and treatment response to peginterferon plus ribavirin for chronic hepatitis C patients
Ming-Yen Hsieh, Chia-Yen Dai, Li-Po Lee, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine
|
August 30, 2006
Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy
Ming-Lung Yu, Wan-Long Chuang, Chia-Yen Dai, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine
|
August 30, 2006
Polymorphism of interferon-gamma gene at position +874 and clinical characteristics of chronic hepatitis C
Chia-Yen Dai, Wan-Long Chuang, Ming-Yen Hsieh, et al.
Page
of 9